Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Caveolae-Mediated Extracellular Vesicle (CMEV) Signaling of Polyvalent Polysaccharide Vaccination: A Host-Pathogen Interface Hypothesis. | Pharmaceutics | 2022 | 36559147 | PubTator, text mining | PubMed |
| Filoviruses: Innate Immunity, Inflammatory Cell Death, and Cytokines. | Pathogens | 2022 | 36558734 | PubTator, text mining | PubMed |
| Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future. | Molecules | 2022 | 36557960 | PubTator, text mining | PubMed |
| Drug Repositioning Applied to Cardiovascular Disease in Mucopolysaccharidosis. | Life (Basel) | 2022 | 36556450 | PubTator, text mining | PubMed |
| The Role of microRNAs in Inflammation. | Int J Mol Sci | 2022 | 36555120 | PubTator, text mining | PubMed |
| Expression of Steroid Receptor RNA Activator 1 (SRA1) in the Adipose Tissue Is Associated with TLRs and IRFs in Diabesity. | Cells | 2022 | 36552771 | PubTator, text mining | PubMed |
| The Role of the Innate Immune System in Wear Debris-Induced Inflammatory Peri-Implant Osteolysis in Total Joint Arthroplasty. | Bioengineering (Basel) | 2022 | 36550970 | PubTator, text mining | PubMed |
| An overview of PROTACs: a promising drug discovery paradigm. | Mol Biomed | 2022 | 36536188 | PubTator, text mining | PubMed |
| Alternative pre-mRNA splicing as a mechanism for terminating Toll-like Receptor signaling. | Front Immunol | 2022 | 36531997 | PubTator, text mining | PubMed |
| IL-1β enhances cell viability and decreases 5-FU sensitivity in novel colon cancer cell lines derived from African American patients. | Front Oncol | 2022 | 36531053 | PubTator, text mining | PubMed |
| Pathway expression analysis. | Sci Rep | 2022 | 36528702 | PubTator, text mining | PubMed |
Network-Based Elaboration of the Efficacy of the Dachangshu (BL25) and Tianshu (ST25) Points in the Treatment of Functional Constipation in Children through Inflammation, Adipocytokine, or Leptin Pathways. | Evid Based Complement Alternat Med | 2022 | 36523422 | PubTator, text mining | PubMed |
| Splicing factor deficits render hematopoietic stem and progenitor cells sensitive to STAT3 inhibition. | Cell Rep | 2022 | 36516770 | PubTator, text mining | PubMed |
| Mitogen Activated Protein Kinase (MAPK) Activation, p53, and Autophagy Inhibition Characterize the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein Induced Neurotoxicity. | Cureus | 2022 | 36514706 | PubTator, text mining | PubMed |
| Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis. | J Neuroinflammation | 2022 | 36510261 | PubTator, text mining | PubMed |
| The relationship between 896A/G (rs4986790) polymorphism of TLR4 and infectious diseases: A meta-analysis. | Front Genet | 2022 | 36506333 | PubTator, text mining | PubMed |
| Zanubrutinib plus salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma. | Front Immunol | 2022 | 36505470 | PubTator, text mining | PubMed |
| Recent Update on the Anti-Inflammatory Activities of Propolis. | Molecules | 2022 | 36500579 | PubTator, text mining | PubMed |
| Targeted Protein Degradation: Clinical Advances in the Field of Oncology. | Int J Mol Sci | 2022 | 36499765 | PubTator, text mining | PubMed |
| The PI3K/Akt Pathway in Meta-Inflammation. | Int J Mol Sci | 2022 | 36499659 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=30